These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 17603331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Topical pimecrolimus 1% for the treatment of pruritic external auditory canals.
    Djalilian HR, Memar O.
    Laryngoscope; 2006 Oct; 116(10):1809-12. PubMed ID: 17003726
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
    Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM.
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of cutaneous lupus with Elidel.
    Zabawski E.
    Dermatol Online J; 2002 Oct; 8(2):25. PubMed ID: 12546779
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.
    Mensing CO, Mensing CH, Mensing H.
    Int J Dermatol; 2008 Sep; 47(9):960-4. PubMed ID: 18937664
    [Abstract] [Full Text] [Related]

  • 12. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
    Werfel T.
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
    [Abstract] [Full Text] [Related]

  • 13. [New treatment approach. Patients with neurodermatitis need less cortisone].
    MMW Fortschr Med; 2003 Feb 06; 145(6):59. PubMed ID: 12619368
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discordant results with pimecrolimus 1% cream in the treatment of plasma cell balanitis.
    Stinco G, Piccirillo F, Patrone P.
    Dermatology; 2009 Feb 06; 218(2):155-8. PubMed ID: 18832808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pimecrolimus: skin disposition after topical administration in minipigs in vivo and in human skin in vitro.
    Gschwind HP, Waldmeier F, Zollinger M, Schweitzer A, Grassberger M.
    Eur J Pharm Sci; 2008 Jan 06; 33(1):9-19. PubMed ID: 17996430
    [Abstract] [Full Text] [Related]

  • 19. [Selective calcineurin inhibitor. Neurodermatitis patients need fewer corticoids].
    MMW Fortschr Med; 2002 Nov 14; 144(46):70. PubMed ID: 12534090
    [No Abstract] [Full Text] [Related]

  • 20. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
    Goldstein AT, Thaçi D, Luger T.
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep 14; 146(1):22-9. PubMed ID: 19631446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.